Primary autoimmune hemolytic anemia (P-AIHA) is a relatively uncommon and hetereogeneous disease characterized by the destruction of red blood cells due to anti-erythrocyte autoantibodies (AeAbs) in the absence of an associated disease [1–3]. Secondary AHIA is frequently associated with lymphoproliferative diseases (LD) in particular, chronic lymphocytic leukemia, aggressive or indolent lymphomas, autoimmune disorders, malignancies other than lymphoid, and infections [1,2,4]. On the hypothetical assumption that in a significant proportion of cases defined as P-AIHA the clinical heterogeneity could be due to an ignored associated disease, we retrospectively analyzed the clinical characteristics and outcome of patients with a diagnosis of P-AIHA based on a diagnostic work-up aimed at excluding or identifying an associated disease. ...

Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up / Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 1096-8652. - ELETTRONICO. - 91:7(2016), pp. E319-E320. [10.1002/ajh.24379]

Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up

MAURO, Francesca Romana;Coluzzi, S;ARMIENTO, DANIELE;FERRETTI, ANTONIETTA;GIOVANNETTI, GIANLUCA;COLAFIGLI, GIOIA;MOLICA, MATTEO;LA ROCCA, URSULA;CARONNA, Roberto;GUARINI, Anna;GIRELLI, Gabriella;FOA, Roberto
2016

Abstract

Primary autoimmune hemolytic anemia (P-AIHA) is a relatively uncommon and hetereogeneous disease characterized by the destruction of red blood cells due to anti-erythrocyte autoantibodies (AeAbs) in the absence of an associated disease [1–3]. Secondary AHIA is frequently associated with lymphoproliferative diseases (LD) in particular, chronic lymphocytic leukemia, aggressive or indolent lymphomas, autoimmune disorders, malignancies other than lymphoid, and infections [1,2,4]. On the hypothetical assumption that in a significant proportion of cases defined as P-AIHA the clinical heterogeneity could be due to an ignored associated disease, we retrospectively analyzed the clinical characteristics and outcome of patients with a diagnosis of P-AIHA based on a diagnostic work-up aimed at excluding or identifying an associated disease. ...
Autoimmune hemolytic anemia
01 Pubblicazione su rivista::01f Lettera, Nota
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up / Mauro, Francesca Romana; Coluzzi, S; Paoloni, F; Trastulli, F; Armiento, Daniele; Ferretti, Antonietta; Giovannetti, Gianluca; Colafigli, Gioia; Molica, Matteo; LA ROCCA, Ursula; De Propris, Ms; Caronna, Roberto; Morano, G; Guarini, Anna; Girelli, Gabriella; Foa, Roberto. - In: AMERICAN JOURNAL OF HEMATOLOGY. - ISSN 1096-8652. - ELETTRONICO. - 91:7(2016), pp. E319-E320. [10.1002/ajh.24379]
File allegati a questo prodotto
File Dimensione Formato  
Mauro_Autoimmune-hemolytic-anemia_2016.pdf

accesso aperto

Note: articolo principale
Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 101 kB
Formato Adobe PDF
101 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/868549
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact